Clinical Trials Browser

NIH × Interventional × Neurotoxicity Syndromes × Clear all

NCT00018967 2015-04-30

Carboxypeptidase-G2 in Treating Nervous System Toxic Effects in Patients Given an Overdose of Intrathecal Methotrexate

Phase NA Completed

10 enrolled

Neurotoxicity Syndromes

NCT00274885 2011-12-05

Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer

Phase 4 Unknown

58 enrolled

GastrointestinalSarcoma

Anus Neoplasms, Appendiceal Neoplasms, Bile Duct Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms, Neurotoxicity Syndromes, Gastrointestinal Stromal Tumors

NCT00884767 2009-07-08

Biomarkers in Predicting Neurotoxicity in Patients With Colorectal Cancer Receiving Oxaliplatin

Phase 2 Unknown

206 enrolled

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms, Neurotoxicity Syndromes

NCT00001689 2008-03-04

A Pharmacokinetic and Pharmacodynamic Study of Vincristine in Children With Leukemia

Phase 1 Completed

90 enrolled

LymphoidOther hematologic neoplasm

Leukemia, Neurotoxicity Syndromes, Precursor Cell Lymphoblastic Leukemia-Lymphoma